Evaxion Biotech (EVAX) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Evaxion Biotech has announced the resignation of Jesper Nissen, the Interim Chief Financial Officer and Chief Operating Officer, effective no later than October 31, 2024. The departure is due to personal reasons and not related to any company disagreements. The firm is now actively seeking a new CFO to fill the vacant role.
For further insights into EVAX stock, check out TipRanks’ Stock Analysis page.